U.S. markets closed

Oliveda International, Inc. (OLVI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0975+0.0100 (+11.43%)
At close: 3:21PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0875
Open0.0955
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0910 - 0.0975
52 Week Range0.0128 - 0.6500
Volume7,270
Avg. Volume89,903
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    Oliveda International, Inc. (OLVI) Announces Plan for Subsidiary Regulation A+ Offering

    Santa Monica, CA, March 01, 2021 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI), a leading international natural cosmetics and wearable beauty and health technology innovator, today announced the intention of its wholly owned Oliveda Group Inc. subsidiary, a California corporation, to file a Regulation A+ Tier 2 stock offering to raise up to $15 million in 2021. Proceeds of the planned offering are currently targeted for expansion of Oliveda operations in the United States and will only involve Oliveda Group stock, not the stock of Oliveda International, Inc. Oliveda Group Inc.’s U.S. expansion plans include new Oliveda flagship stores in Los Angeles (Abbot Kinney Boulevard area), New York, San Francisco, and Miami; broader marketing of Oliveda products throughout the country; ownership of olive tree groves, the launch of new products; and potentially the acquisition of additional beauty and health companies. Legal counsel has been retained and work has been initiated on Form 1-A offering circular, which is expected to be filed with the U.S. Securities and Exchange Commission as soon as it is finalized. The company has prioritized increasing the value of its subsidiary operations with minimal dilution to OLVI shareholders, which is why the company’s issued and outstanding common stock has remained virtually unchanged over the past four years. About Oliveda International, Inc. Founded in 2003 by German real estate investor Thomas Lommel, Oliveda International, Inc. is a leading international natural cosmetic company in the premium segment. The company has also developed a globally unique wearable beauty and health technology. In addition to online sales and a global branch network of 650 retail stores, the company’s wholly owned Oliveda Deutschland GmbH second-tier subsidiary operates flagship stores, Olive Tree Pharmacy, in Berlin and Dusseldorf with plans to open new locations in Los Angeles, Taipei and Seoul. Overall, the company believes that it will be able to operate a total of 60 of its own flagship stores worldwide and increase the retail store network worldwide to 1,200 over the next five years. Through subsidiary operations, Oliveda International is the largest investor in eco-certified mountain olive trees as well as the largest conservationist in Arroyomolinos de Leó, Spain. Further information on Oliveda International can be found at http://www.oliveda.com, https://us.oliveda.com and http://www.olivetreepeople.com. Forward-Looking StatementsThis press release may contain statements, estimates or projections that constitute "forward-looking statements" pursuant to the safe harbor provisions of the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties, which may be found in the Company’s filings with OTC Markets Group Inc., that could cause actual results to differ materially from the Company's historical experience and present expectations or projections. Investors should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Company expressly disclaims any obligation or intention to publicly update or revise any forward-looking statements unless otherwise required by law. ### CONTACT: Oliveda International, Inc. Investor Relations 619-202-7456 olvi@advanceprgroup.com

  • GlobeNewswire

    Oliveda International, Inc. (OLVI) Reports 40% Sales Increase for 2020 in One of the Most Challenging Years for Beauty Retailers

    Santa Monica, CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI), a leading international natural cosmetics and wearable beauty and health technology innovator, is reporting that despite one of the most challenging business environments in decades, with store closures, lockdowns, and limitations on in-person shopping, the company expects its 2020 year-end financial report to reflect a 40% increase in sales over the previous year (2019). In a year when industry analysts projected 20-40% decreases in sales for the beauty industry, Oliveda was able to increase sales by such a significant percentage through a strong performance in online orders. The increase in sales is expected to be reflected in the company’s upcoming 2020 year-end financial report, which is due to be posted on the OTC Markets website on or about March 31, 2021. For the first time in its history, the company will have completed audited financials for its wholly owned Oliveda Group subsidiary from 2018 through 2020. The company has also completed audited financials for Oliveda International for the 2018 and 2019 year-end periods. About Oliveda International, Inc. Founded in 2003 by German real estate investor Thomas Lommel, Oliveda International, Inc. is a leading international natural cosmetic company in the premium segment. The company has also developed a globally unique wearable beauty and health technology. In addition to online sales and a global branch network of 650 retail stores, the company’s wholly owned Oliveda Deutschland GmbH second-tier subsidiary operates flagship stores, Olive Tree Pharmacy, in Berlin and Dusseldorf with plans to open new locations in Los Angeles, Taipei and Seoul. Overall, the company believes that it will be able to operate a total of 60 of its own flagship stores worldwide and increase the retail store network worldwide to 1,200 over the next five years. Through subsidiary operations, Oliveda International is the largest investor in eco-certified mountain olive trees as well as the largest conservationist in Arroyomolinos de Leó, Spain. Further information on Oliveda International can be found at http://www.oliveda.com, https://us.oliveda.com and http://www.olivetreepeople.com. Forward-Looking StatementsThis press release may contain statements, estimates or projections that constitute "forward-looking statements" pursuant to the safe harbor provisions of the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties, which may be found in the Company’s filings with OTC Markets Group Inc., that could cause actual results to differ materially from the Company's historical experience and present expectations or projections. Investors should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Company expressly disclaims any obligation or intention to publicly update or revise any forward-looking statements unless otherwise required by law. CONTACT: Oliveda International, Inc. Investor Relations 619-202-7456 olvi@advanceprgroup.com

  • GlobeNewswire

    Oliveda International, Inc. (OLVI) Targets Growth in Pregnancy Beauty After High Profile Mention

    In a video for Vouge, supermodel Gigi Hadid mentions her use of clean and natural Oliveda during her recent pregnancySanta Monica, CA, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI), a leading international natural cosmetics and wearable beauty and health technology innovator, is making a strong push into the growing pregnancy beauty market on the heels of a mention by international supermodel and beauty influencer Gigi Hadid, who stated that she used Oliveda products produced by Oliveda International’s second-tier subsidiary during her recent pregnancy. The video can be seen at can been seen at https://www.vogue.com/article/gigi-hadid-beauty-secrets. According to industry research firms, the global pregnancy care products market size was valued at over $23 million in 2019 and is expected to reach almost $42 million by 2026, growing at a CAGR of approximately 6% during the 2020 to 2026 forecast period. In recent years there has been a reported shift away from traditional home skincare remedies during pregnancy to commercially available products. At the same time, rising awareness of natural, holistic skincare solutions is driving consumers attention towards use of safer and more effective skincare products. The market for organic pregnancy care products is rising both globally and in the United States. During the sensitive months of pregnancy, our demands on everything that comes especially close to us change. It is even more important to provide and pamper our largest organ, the skin, which protects and embraces us for a lifetime, with active ingredients that are 100% beneficial, caring and nourishing, and contain 0% harmful or inactive ingredients. Our belief is that Gigi Hadid's skin care routine during her pregnancy is a sign of her trust in the power of nature - and in pure Oliveda products. Our recommendations for demanding skin during pregnancy include: For the complexion – the regenerating Jasmine Face Oil F27; Against impurities and irritations of the skin – the anti-inflammatory and soothing SOS Skin Gel B14; For the body – Oliveda Body Oil Lavender Vanilla B28. Oliveda Clean Beauty, without harmful or ineffective ingredients, but 100% pure, highly effective nature. About Oliveda International, Inc. Founded in 2003 by German real estate investor Thomas Lommel, Oliveda International, Inc. is a leading international natural cosmetic company in the premium segment. The company has also developed a globally unique wearable beauty and health technology. In addition to online sales and a global branch network of 650 retail stores, the company’s wholly owned Oliveda Deutschland GmbH second-tier subsidiary operates flagship stores, Olive Tree Pharmacy, in Berlin and Dusseldorf with plans to open new locations in Los Angeles, Taipei and Seoul. Overall, the company believes that it will be able to operate a total of 60 of its own flagship stores worldwide and increase the retail store network worldwide to 1,200 over the next five years. Through subsidiary operations, Oliveda International is the largest investor in eco-certified mountain olive trees as well as the largest conservationist in Arroyomolinos de Leó, Spain. Further information on Oliveda International can be found at http://www.oliveda.com, https://us.oliveda.com and http://www.olivetreepeople.com. Forward-Looking StatementsThis press release may contain statements, estimates or projections that constitute "forward-looking statements" pursuant to the safe harbor provisions of the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties, which may be found in the Company’s filings with OTC Markets Group Inc., that could cause actual results to differ materially from the Company's historical experience and present expectations or projections. Investors should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Company expressly disclaims any obligation or intention to publicly update or revise any forward-looking statements unless otherwise required by law. CONTACT: Oliveda International, Inc. Investor Relations 619-452-6075 olvi@advanceprgroup.com